Absence of bone sialoprotein (BSP) impairs primary bone formation and resorption: The marrow ablation model under PTH challenge

Bone

Volumn 50, Issue 5, 2012, Pages 1064-1073

  Wade Gueye, Ndéye Marième ^a,b,c   Boudiffa, Maya ^a,b,c   Vanden Bossche, Arnaud ^a,b,c   Laroche, Norbert ^a,b,c   Aubin, Jane E ^d   Vico, Laurence ^a,b,c   Lafage Proust, Marie Hélène ^a,b,c   Malaval, Luc ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ JEAN MONNET   (France)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bone marrow ablation; Bone modeling; Bone sialoprotein; Primary bone; SIBLING proteins

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; BONE SIALOPROTEIN; DENTIN MATRIX PROTEIN 1; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; PARATHYROID HORMONE; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2;

ABLATION THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEFECT; BONE MARROW; BONE MINERALIZATION; BONE TURNOVER; CELL DIFFERENTIATION; CONTROLLED STUDY; CORTICAL BONE; EMBRYO; ENCHONDRAL OSSIFICATION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PHENOTYPE; PROTEIN EXPRESSION; TRABECULAR BONE;

ABLATION TECHNIQUES; ANIMALS; BIOLOGICAL MARKERS; BONE MARROW; BONE RESORPTION; CELL COUNT; CELL DIFFERENTIATION; FEMUR; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; MALE; MICE; MODELS, BIOLOGICAL; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPONTIN; PARATHYROID HORMONE; RNA, MESSENGER;

EID: 84857963574     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.02.014     Document Type: Article

References (27)

1. Amsel S., Maniatis A., Tavassoli M., Crosby W.H. The significance of intramedullary cancellous bone formation in the repair of bone marrow tissue. Anat Rec 1969, 164:101-111.
2. Andreassen T.T., Cacciafesta V. Intermittent parathyroid hormone treatment enhances guided bone regeneration in rat calvarial bone defects. J Craniofac Surg 2004, 15:424-427. discussion 428-9.
3. Bab I., Passi-Even L., Gazit D., Sekeles E., Ashton B.A., Peylan-Ramu N., et al. Osteogenesis in in vivo diffusion chamber cultures of human marrow cells. Bone Miner 1988, 4:373-386.
4. Boudiffa M., Wade-Gueye N.M., Guignandon A., Vanden-Bossche A., Sabido O., Aubin J.E., et al. Bone sialoprotein deficiency impairs osteoclastogenesis and mineral resorption in vitro. J Bone Miner Res 2010, 25:2393-2403.
5. Chen J., McKee M.D., Nanci A., Sodek J. Bone sialoprotein mRNA expression and ultrastructural localization in fetal porcine calvarial bone: comparisons with osteopontin. Histochem J 1994, 26:67-78.
6. Chen J., Shapiro H.S., Sodek J. Development expression of bone sialoprotein mRNA in rat mineralized connective tissues. J Bone Miner Res 1992, 7:987-997.
7. Chen X.D., Allen M.R., Bloomfield S., Xu T., Young M. Biglycan-deficient mice have delayed osteogenesis after marrow ablation. Calcif Tissue Int 2003, 72:577-582.
8. Fisher L.W., Fedarko N.S. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res 2003, 44(Suppl. 1):33-40.
9. Frolik C.A., Black E.C., Cain R.L., Satterwhite J.H., Brown-Augsburger P.L., Sato M., et al. Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure. Bone 2003, 33:372-379.
10. Ganss B., Kim R.H., Sodek J. Bone sialoprotein. Crit Rev Oral Biol Med 1999, 10:79-98.
11. Gordon J.A., Tye C.E., Sampaio A.V., Underhill T.M., Hunter G.K., Goldberg H.A. Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro. Bone 2007, 41:462-473.
12. Gorski J.P. Is all bone the same? Distinctive distributions and properties of non-collagenous matrix proteins in lamellar vs. woven bone imply the existence of different underlying osteogenic mechanisms. Crit Rev Oral Biol Med 1998, 9:201-223.
13. Gorski J.P., Apone S., Shaffer K.A., Batchelder A., Jean W., Williams J.A., et al. Hypercalcemia during the osteogenic phase after rat marrow ablation coincides with increased bone resorption assessed by the NTx marker. Bone 2000, 27:103-110.
14. Gorski J.P., Wang A., Lovitch D., Law D., Powell K., Midura R.J. Extracellular bone acidic glycoprotein-75 defines condensed mesenchyme regions to be mineralized and localizes with bone sialoprotein during intramembranous bone formation. J Biol Chem 2004, 279:25455-25463.
15. Greenspan S.L., Bone H.G., Ettinger M.P., Hanley D.A., Lindsay R., Zanchetta J.R., et al. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 2007, 146:326-339.
16. Hunter G.K., Goldberg H.A. Modulation of crystal formation by bone phosphoproteins: role of glutamic acid-rich sequences in the nucleation of hydroxyapatite by bone sialoprotein. Biochem J 1994, 302(Pt 1):175-179.
17. Hunter G.K., Hauschka P.V., Poole A.R., Rosenberg L.C., Goldberg H.A. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 1996, 317(Pt 1):59-64.
18. Iida-Klein A., Hughes C., Lu S.S., Moreno A., Shen V., Dempster D.W., et al. Effects of cyclic versus daily hPTH(1-34) regimens on bone strength in association with BMD, biochemical markers, and bone structure in mice. J Bone Miner Res 2006, 21:274-282.
19. Malaval L., Monfoulet L., Fabre T., Pothuaud L., Bareille R., Miraux S., et al. Absence of bone sialoprotein (BSP) impairs cortical defect repair in mouse long bone. Bone 2009, 45:853-861.
20. Malaval L., Wade-Gueye N.M., Boudiffa M., Fei J., Zirngibl R., Chen F., et al. Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 2008, 205:1145-1153.
21. Monfoulet L., Malaval L., Aubin J.E., Rittling S.R., Gadeau A.P., Fricain J.C., et al. Bone sialoprotein, but not osteopontin, deficiency impairs the mineralization of regenerating bone during cortical defect healing. Bone 2010, 46:447-452.
22. Nagy A., Rossant J., Nagy R., Abramow-Newerly W., Roder J.C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A 1993, 90:8424-8428.
23. Patt H.M., Maloney M.A. Bone marrow regeneration after local injury: a review. Exp Hematol 1975, 3:135-148.
24. Sawae Y., Sahara T., Kawana F., Sasaki T. Effects of enamel matrix derivative on mineralized tissue formation during bone wound healing in rat parietal bone defects. J Electron Microsc (Tokyo) 2002, 51:413-423.
25. Wade-Gueye N.M., Boudiffa M., Laroche N., Vanden-Bossche A., Fournier C., Aubin J.E., et al. Mice Lacking Bone Sialoprotein (BSP) Lose Bone after Ovariectomy and Display Skeletal Site-Specific Response to Intermittent PTH Treatment. Endocrinology 2010, 151:5103-5113.
26. Yamashita T., Yoshitake H., Tsuji K., Kawaguchi N., Nabeshima Y., Noda M. Retardation in bone resorption after bone marrow ablation in klotho mutant mice. Endocrinology 2000, 141:438-445.
27. Zhang Q., Cuartas E., Mehta N., Gilligan J., Ke H.Z., Saltzman W.M., et al. Replacement of bone marrow by bone in rat femurs: the bone bioreactor. Tissue Eng Part A 2008, 14:237-246.